Literature DB >> 117497

The in vivo distribution of an antidepressant drug (DMI) in male and female rats.

A Biegon, D Samuel.   

Abstract

The accumulation of IP injected 3H-desipramine (DMI) in the brain and in the liver has been studied in both male and female rats. The total amount of DMI in the brains of females is 2 to 4 times that found in the brains of males. In females the amount of DMI is highest on the day of estrus and lowest on proestrus. This sex difference was not found following the injections of another psychoactive drug, 3H-chlorpromazine. In both males and females the level of DMI in the cortex and caudate is slightyl higher than in the hippocampus, septum and hypothalamus. The pharmaco-kinetics and dose dependence of the accumulation of DMI are also similar in males and females. Maximal levels are reached in the liver in less than 15 min, whereas in the brain it takes 30 min. The decline of radioactivity in the liver is faster than in brain. There is no saturation in the amount of DMI taken in brain. There is no saturation in the amount of DMI taken up in brain or liver in the dose range up to 40 mg/kg. The sex difference in the amount of 3H-DMI in brain, which may be the result of sex-dependent metabolism in liver microsomes, may explain the male-female differences in reaction to antidepressants.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 117497     DOI: 10.1007/bf00492213

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  22 in total

1.  Demethylation of imipramine in male and female rats.

Authors:  G R PSCHEIDT
Journal:  Biochem Pharmacol       Date:  1962-06       Impact factor: 5.858

2.  Tricyclic antidepressants: therapeutic properties and affinity for alpha-noradrenergic receptor binding sites in the brain.

Authors:  D C U'Prichard; D A Greenberg; P P Sheehan; S H Snyder
Journal:  Science       Date:  1978-01-13       Impact factor: 47.728

Review 3.  Factors influencing the metabolism of tricyclic antidepressants. Studies on interactions and first pass elimination.

Authors:  L F Gram
Journal:  Dan Med Bull       Date:  1977-06

4.  Age-sex differences in response to antidepressant drugs.

Authors:  A Raskin
Journal:  J Nerv Ment Dis       Date:  1974-08       Impact factor: 2.254

5.  Competition of phenothiazines with oestradiol for oestradiol receptors in rat brain.

Authors:  J Shani; Y Givant; F G Sulman; U Eylath; B Eckstein
Journal:  Neuroendocrinology       Date:  1971       Impact factor: 4.914

6.  Chlorpromazine adsorption to brain regions.

Authors:  W O Kwant; P Seeman
Journal:  Biochem Pharmacol       Date:  1971-08       Impact factor: 5.858

7.  Brain levels of imipramine and desipramine after combined treatment with these drugs in rats.

Authors:  A Jori; D Bernardi; G Muscettola; S Garattini
Journal:  Eur J Pharmacol       Date:  1971-06       Impact factor: 4.432

8.  Levels of chlorpromazine and its active metabolites in rat brain and the relationship to central monoamine metabolism and prolactin secretion.

Authors:  G Alfredsson; F A Wiesel; P Skett
Journal:  Psychopharmacology (Berl)       Date:  1977-06-06       Impact factor: 4.530

9.  Quantitative determination of imipramine and desipramine in human blood plasma by direct densitometry of thin-layer chromatograms.

Authors:  A Nagy; L Treiber
Journal:  J Pharm Pharmacol       Date:  1973-08       Impact factor: 3.765

10.  Self-inhibiting action of nortriptylin's antidepressive effect at high plasma levels: a randomized double-blind study controlled by plasma concentrations in patients with endogenous depression.

Authors:  P Kragh-Sorensen; C E Hansen; P C Baastrup; E F Hvidberg
Journal:  Psychopharmacologia       Date:  1976-02-02
View more
  10 in total

1.  Potentiation of the action of adenosine on cerebral cortical neurones by the tricyclic antidepressants.

Authors:  J W Phillis
Journal:  Br J Pharmacol       Date:  1984-10       Impact factor: 8.739

2.  Appropriate dosing regimens for treating juvenile rats with desipramine for neuropharmacological and behavioral studies.

Authors:  Megan E Kozisek; Jean D Deupree; William J Burke; David B Bylund
Journal:  J Neurosci Methods       Date:  2007-02-22       Impact factor: 2.390

3.  Clomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms. A double-blind cross-over study.

Authors:  S H Sindrup; L F Gram; T Skjold; E Grodum; K Brøsen; H Beck-Nielsen
Journal:  Br J Clin Pharmacol       Date:  1990-11       Impact factor: 4.335

4.  Frequency-dependent block of field potentials in the rat hippocampal slice caused by tricyclic antidepressants.

Authors:  R Anwyl; M J Rowan
Journal:  Br J Pharmacol       Date:  1985-09       Impact factor: 8.739

5.  Role of medial prefrontal, entorhinal, and occipital 5-HT in cocaine-induced place preference and hyperlocomotion: evidence for multiple dissociations.

Authors:  M E Pum; R J Carey; J P Huston; C P Müller
Journal:  Psychopharmacology (Berl)       Date:  2008-09-02       Impact factor: 4.530

6.  The persistent membrane retention of desipramine causes lasting inhibition of norepinephrine transporter function.

Authors:  Meng-Yang Zhu; Patrick B Kyle; Arthur S Hume; Gregory A Ordway
Journal:  Neurochem Res       Date:  2004-02       Impact factor: 3.996

7.  Lack of effect of mianserin on the symptoms of diabetic neuropathy.

Authors:  S H Sindrup; C Tuxen; L F Gram; E Grodum; T Skjold; K Brøsen; H Beck-Nielsen
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

8.  Biphasic effect of tricyclic antidepressants on the release of norepinephrine from the adrenergic nerves of the rabbit heart.

Authors:  G T Somogyi; J M Perel
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

9.  Relationships between brain concentrations of desipramine and paradoxical sleep inhibition in the rat.

Authors:  P Baumann; J M Gaillard; M Perey; J C Justafré; P Le
Journal:  J Neural Transm       Date:  1983       Impact factor: 3.575

10.  Influence of acute or chronic administration of ovarian hormones on the effects of desipramine in the forced swim test in female rats.

Authors:  Aparna Shah; Alan Frazer
Journal:  Psychopharmacology (Berl)       Date:  2014-03-04       Impact factor: 4.530

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.